Eduard Vaynberg, MD
Pain Medicine · Boston, MANPI 1922084987
Payments from drug & device makers
What this record shows
This record is dominated by speaking fees: $23,306 of the $31,669 with a category attached, or 73.6%. Medtronic accounts for 82.3% of it on its own, with 6 other manufacturers making up the rest. Reporting peaked in 2019 at $9,519 and has fallen 92.9% since, to $676 in 2025. Among pain medicine clinicians in MA with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 83 payments — averaging $381.56 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Medtronic$26K
- Vertiflex, Inc.$2K
- Boston Scientific$2K
- BD$850
- Pacira Pharmaceuticals Incorporated$273
- Abbott$153
- plus $29 from 1 others
Across 1 payment — averaging $345.00 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Medtronic$345
What the payments were for
- Speaking & faculty fees$23,30674%
- Travel & lodging$3,12110%
- Food & beverage$5,24217%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Medtronic(2 entities) | 56 | $26,058 |
| Vertiflex, Inc. | 7 | $2,246 |
| Boston Scientific | 15 | $2,060 |
| BD | 1 | $850 |
| Pacira Pharmaceuticals Incorporated | 1 | $273 |
| Abbott | 1 | $153 |
| SPR Therapeutics, Inc | 2 | $29 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- INTELLIS ADAPTIVESTIM$9,429
- ADAPTIVESTIM$5,000
- INTELLIS$4,788
- RESTORE$2,478
- VECTRIS$2,272
- Superion ISS$2,127
- SPECTRA WAVEWRITER$1,557
- INCEPTIV$485
- EXPAREL$273
- VANTA ADAPTIVESTIM$197
- AUTOFILL$185
- PROCLAIM$153
- ACTIVOS 10 BONE CEMENT$150
- ACTIVA$131
- SYNCHROMED$120
- Vanta$118
How this compares
$31,669 in reported general payments places this provider in the 90th percentile of 137 pain medicine providers in Massachusetts.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Fentanyl | 12 | $1,260 |
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 13 | $481 |
Paid to pharmacies, not to this prescriber.
Other pain medicine in Boston
- Thomas SimopoulosBoston$181K
- Arti OriBoston$62K
- Christine SangBoston$56K
- David HaoBoston$16K
- Erika YihBoston$8K
- Samuel AngBoston$7K
- Kevin VuBoston$6K
- Brenda LeeBoston$6K
- Steven MachBoston$5K
- Rupeng LiBoston$4K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.